7th Jul 2021
New European guidelines on the diagnosis and therapy of pancreatic exocrine insufficiency are under development
UEG, EPC, EDS, ESPGHAN, ESPEN and ESPCG evidence-based recommendations
Now financially supported by the UEG
The UEG has agreed to award funds for the development of the ‘European Guideline on the Diagnosis and Therapy of Pancreatic Exocrine Insufficiency’.
The need for this guideline is based on the wide variability in the diagnostic and therapeutic approach to pancreatic exocrine insufficiency in different clinical scenarios and different centers across Europe, as well as and in non-European countries.
The EPC has invited other UEG Specialist Member Societies to join this project with the aim of developing a transversal multidisciplinary guideline to be adopted by all specialties around Europe. The following societies have confirmed their participation:
- European Digestive Surgery (EDS)
- European Society for Primary Care Gastroenterology (ESCPG)
- European Society for Paediatric Gastroenterology, Hepatology and Nutrition (ESPGHAN)
- European Society for Clinical Nutrition and Metabolism (ESPEN)
In addition, several UEG National Member Societies and Patients’ Associations have endorsed the proposal.
The following EPC members constitute the steering committee responsible for the design of the guideline protocol and UEG application:
J. Enrique Domínguez-Muñoz (Spain, lead), Matthias Löhr (Sweden, co-chair), Daniel de la Iglesia-García (Spain, scientific secretary), Djuna Cahen (Netherlands), Gabriele Capurso (Italy), Natalya Gubergrits (Ukraine), Peter Hegyi (Hungary), Vinciane Rebours (France) and Jonas Rosenthal (Germany).